Company Background
GondolaBio is a collection of biopharmaceutical companies focused on developing next-generation therapeutics for genetic diseases. Originally carved out of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. GondolaBio aims to leverage cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases.
One of GondolaBio’s subsidiaries is an early preclinical stage biotechnology company developing a novel best-in-class therapeutic for a rare, severe genetic disease, advancing toward first-in-human clinical studies.
Who You Are
We seek a top clinical development executive to be responsible for building and executing the clinical development plan for our lead program. This role will be primarily accountable for clinical trial execution encompassing study design, oversight and management. This job requires excellent communication and interpersonal skills as well as medical monitoring, clinical operations, KOL and investigator engagement, and drug safety experience. This role will serve as the first dedicated clinical development leader for the program.
Responsibilities
Education, Experience & Skills Requirements
What We Offer:
The base pay range for this position is $288,000 to $380,000 per year. The actual compensation offered will be determined based on a number of job-related factors, including experience, skills, qualifications, and location. A bonus plan and equity will also be offered.

Morgan Stanley

Edges Wellness Center LLC

WSP in Canada

Digitalenta

Cox Automotive Inc.

GondolaBio

GondolaBio